Page last updated: 2024-08-21

chenodeoxycholic acid and HIV Coinfection

chenodeoxycholic acid has been researched along with HIV Coinfection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bhagani, S; Guaraldi, G; Ingiliz, P; Lemoine, M; Marzolini, C; Maurice, JB; Milic, J; Monteith, K; Morse, CG; Price, JC; Sebastiani, G; Tsochatzis, E1
Bridges, AS; Brouwer, KL; Corbett, AH; Kashuba, AD; McRae, M; Rezk, NL; Tien, HC1

Other Studies

2 other study(ies) available for chenodeoxycholic acid and HIV Coinfection

ArticleYear
New Drugs for NASH and HIV Infection: Great Expectations for a Great Need.
    Hepatology (Baltimore, Md.), 2020, Volume: 71, Issue:5

    Topics: Anti-Retroviral Agents; Chalcones; Chenodeoxycholic Acid; Cholic Acids; Clinical Trials, Phase III as Topic; Drug Interactions; HIV Infections; Humans; Imidazoles; Non-alcoholic Fatty Liver Disease; Propionates; Pyridazines; Sulfoxides; Uracil

2020
Plasma bile acid concentrations in patients with human immunodeficiency virus infection receiving protease inhibitor therapy: possible implications for hepatotoxicity.
    Pharmacotherapy, 2010, Volume: 30, Issue:1

    Topics: Adult; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Chromatography, High Pressure Liquid; Early Diagnosis; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lithocholic Acid; Liver; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Tandem Mass Spectrometry; Taurocholic Acid; Time Factors

2010